From September 28, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for $0 million under the buyback announced on September 28, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.32 USD | +2.79% | -24.37% | +183.76% |
Jun. 04 | Maia Biotechnology Reveals New Clinical Data Showing Thio?s Strong Efficacy in Non-Small Cell Lung Cancer | CI |
May. 21 | MAIA Biotechnology, Inc. announced a financing transaction | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+183.76% | 70.53M | |
+55.55% | 59.34B | |
+43.17% | 40.24B | |
-4.71% | 39.88B | |
-5.56% | 28.55B | |
+13.76% | 27.26B | |
-22.00% | 19.23B | |
+31.50% | 12.61B | |
+2.16% | 12.49B | |
+25.70% | 12.28B |
- Stock Market
- Equities
- MAIA Stock
- News MAIA Biotechnology, Inc.
- Tranche Update on MAIA Biotechnology, Inc.'s Equity Buyback Plan announced on September 28, 2023.